Key result
Stimulant medications are safe in pediatric patients with underlying congenital heart disease, though cardiology consultation is recommended for complex cases.
Why the study?
To review current literature regarding the safety of stimulant medications for the treatment of attention deficit hyperactivity disorder in paediatric congenital heart disease patients.
Are stimulant medications safe for treating attention deficit hyperactivity disorder in paediatric congenital heart disease patients?
Are stimulant medications safe for treating attention deficit hyperactivity disorder in paediatric congenital heart disease patients?
Stimulant medications for ADHD are generally safe in pediatric patients with congenital heart disease, though cardiology consultation is recommended prior to initiation in complex cases.
Answers are grounded in this paper and cite their sources.
Supports stimulant use in mild pediatric CHD by pediatricians; leaves open optimal protocols for complex cases pending prospective data.
AIM: To review current literature regarding the safety of stimulant medications for treatment of attention deficit hyperactivity disorder in paediatric congenital heart disease (CHD) patients. METHODS: Embase, MEDLINE complete, CINAHL complete and Psychology and Behavioural Sciences Collection were searched for relevant articles from January 1980 to July 2022. RESULTS: One hundred and three articles were identified during the initial search after removal of duplicates. Thirty-five articles were selected for review and 11 were included as relevant to the clinical question. CONCLUSIONS: Stimulant medications are safe in patients with underlying CHD. In mild congenital cardiac conditions (ventricular septal defect, atrial septal defect and isolated semilunar valve disease), paediatricians can safely initiate stimulant therapy. With complex CHD cases, cardiology opinion is recommended prior to starting stimulants.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2023) conducted a review in Attention deficit hyperactivity disorder in paediatric congenital heart disease. Stimulant medications was evaluated on Safety. Stimulant medications are safe in pediatric patients with underlying congenital heart disease, though cardiology consultation is recommended for complex cases.
Synapse has enriched 10 related papers. Consider them for comparative context: